BioMark Secures Key Patents in Asia's Largest Markets for Early Lung Cancer Liquid BiopsyPioneering liquid biopsy platform for early lung cancer detection strengthens IP and accelerates commercial strategy in China and Japan diagnostic markets.September 29, 2025 8:30 AM EDT | Source: BioMark Diagnostics, Inc.Vancouver, British Columbia--(Newsfile Corp. - September 29, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark"), a leading developer of liquid biopsy technol ...